Log | Progress In Mind

Log Type	Authored on	Log Message	Log Node	Authored by
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Apoio à saúde mental em tempos de crise	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Dr. Mattingly discute abordagens durante a pandemia	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Анонимен
Newsletter clicked	Tue, 11/08/2022 - 12:04	Clicked https://brazil.progress.im/pt-br/content/equil%C3%ADbrio-vs-burnout-durante-covid-19	Novos medicamentos têm como alvo a CGRP e seus receptores	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Sua atualização semanal em 5 minutos sobre Psiquiatria e Neurologia	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Dra. Deborah Dunsire (CEO Lundbeck) envia mensagem aos profissionais saúde durante a crise do COVID-19	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Saúde Mental no Distanciamento Social	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Estratégias motivacionais para combater o estigma	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Dr. Mattingly discute abordagens durante a pandemia	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Анонимен
Newsletter clicked	Tue, 11/08/2022 - 12:04	Clicked https://brazil.progress.im/pt-br/content/novos-medicamentos-com-anticorpos-monoclonais-t%C3%AAm-como-alvo-cgrp-e-seus-receptores	Novos medicamentos têm como alvo a CGRP e seus receptores	Анонимен
User created	Wed, 10/12/2022 - 13:23	User created		Анонимен
User created	Wed, 10/12/2022 - 13:23	User created		Анонимен
User created	Wed, 10/12/2022 - 13:23	User created		Анонимен
Email verified	Wed, 10/12/2022 - 13:23	Email verified		Анонимен
User created	Wed, 10/12/2022 - 13:23	User created		Анонимен
User created	Wed, 10/12/2022 - 13:23	User created		Анонимен
User created	Wed, 10/12/2022 - 13:23	User created		Анонимен
Newsletter subscribed	Wed, 10/12/2022 - 13:23	Newsletter subscribed - Progress in Mind SEA		Анонимен
User created	Wed, 10/12/2022 - 13:23	User created		Анонимен
User created	Wed, 10/12/2022 - 13:23	User created		Анонимен
Newsletter subscribed	Wed, 10/12/2022 - 13:23	Newsletter subscribed - Progress in Mind SEA		Анонимен
User created	Wed, 10/12/2022 - 13:23	User created		Анонимен

Log Type	Authored on	Log Message	Log Node	Authored by
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Apoio à saúde mental em tempos de crise	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Dr. Mattingly discute abordagens durante a pandemia	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Анонимен
Newsletter clicked	Tue, 11/08/2022 - 12:04	Clicked https://brazil.progress.im/pt-br/content/equil%C3%ADbrio-vs-burnout-durante-covid-19	Novos medicamentos têm como alvo a CGRP e seus receptores	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Sua atualização semanal em 5 minutos sobre Psiquiatria e Neurologia	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Dra. Deborah Dunsire (CEO Lundbeck) envia mensagem aos profissionais saúde durante a crise do COVID-19	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Saúde Mental no Distanciamento Social	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Estratégias motivacionais para combater o estigma	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Dr. Mattingly discute abordagens durante a pandemia	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Анонимен
Newsletter clicked	Tue, 11/08/2022 - 12:04	Clicked https://brazil.progress.im/pt-br/content/novos-medicamentos-com-anticorpos-monoclonais-t%C3%AAm-como-alvo-cgrp-e-seus-receptores	Novos medicamentos têm como alvo a CGRP e seus receptores	Анонимен
User created	Wed, 10/12/2022 - 13:23	User created		Анонимен
User created	Wed, 10/12/2022 - 13:23	User created		Анонимен
User created	Wed, 10/12/2022 - 13:23	User created		Анонимен
Email verified	Wed, 10/12/2022 - 13:23	Email verified		Анонимен
User created	Wed, 10/12/2022 - 13:23	User created		Анонимен
User created	Wed, 10/12/2022 - 13:23	User created		Анонимен
User created	Wed, 10/12/2022 - 13:23	User created		Анонимен
Newsletter subscribed	Wed, 10/12/2022 - 13:23	Newsletter subscribed - Progress in Mind SEA		Анонимен
User created	Wed, 10/12/2022 - 13:23	User created		Анонимен
User created	Wed, 10/12/2022 - 13:23	User created		Анонимен
Newsletter subscribed	Wed, 10/12/2022 - 13:23	Newsletter subscribed - Progress in Mind SEA		Анонимен
User created	Wed, 10/12/2022 - 13:23	User created		Анонимен

Patrocinado por

Progress in Mind Brazil

INSCRIÇÃO NEWSLETTER